Total Payments
$269,204
2024 Payments
$82,553
Companies
31
Transactions
746
Payment Breakdown by Category
Other$182,812 (67.9%)
Consulting$32,841 (12.2%)
Travel$31,972 (11.9%)
Food & Beverage$21,523 (8.0%)
Education$54.97 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $161,799 | 76 | 60.1% |
| Consulting Fee | $32,841 | 13 | 12.2% |
| Travel and Lodging | $31,972 | 89 | 11.9% |
| Food and Beverage | $21,523 | 545 | 8.0% |
| Honoraria | $21,013 | 18 | 7.8% |
| Education | $54.97 | 5 | 0.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Optinose US, Inc. | $88,017 | 163 | $0 (2024) |
| GENZYME CORPORATION | $63,156 | 118 | $0 (2024) |
| ALK-Abello, Inc | $40,066 | 98 | $0 (2024) |
| Regeneron Healthcare Solutions, Inc. | $31,626 | 100 | $0 (2024) |
| GlaxoSmithKline, LLC. | $22,563 | 78 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $6,809 | 13 | $0 (2024) |
| kaleo, Inc. | $4,132 | 32 | $0 (2024) |
| ABBVIE INC. | $2,891 | 9 | $0 (2024) |
| Grifols USA, LLC | $2,863 | 4 | $0 (2024) |
| Blueprint Medicines Corporation | $2,306 | 11 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $82,553 | 115 | GENZYME CORPORATION ($42,496) |
| 2023 | $57,119 | 162 | GENZYME CORPORATION ($19,746) |
| 2022 | $36,869 | 120 | OptiNose US, Inc. ($29,369) |
| 2021 | $26,512 | 79 | ALK-Abello, Inc ($14,579) |
| 2020 | $24,608 | 63 | OptiNose US, Inc. ($13,308) |
| 2019 | $20,458 | 73 | ALK-Abello, Inc ($14,575) |
| 2018 | $18,261 | 68 | Optinose US, Inc. ($6,282) |
| 2017 | $2,825 | 66 | Teva Pharmaceuticals USA, Inc. ($532.81) |
All Payment Transactions
746 individual payment records from CMS Open Payments — Page 1 of 30
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $125.36 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/17/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,597.00 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/14/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $257.91 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 12/10/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $920.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $5,597.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $780.52 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $380.81 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $263.29 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $105.47 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Travel and Lodging | Cash or cash equivalent | $87.00 | General |
| Category: Immunology | ||||||
| 12/05/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | Cash or cash equivalent | $38.32 | General |
| Category: Immunology | ||||||
| 12/03/2024 | GENZYME CORPORATION | — | Consulting Fee | Cash or cash equivalent | $1,599.00 | General |
| 12/03/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $113.77 | General |
| 12/03/2024 | GENZYME CORPORATION | — | Food and Beverage | In-kind items and services | $12.57 | General |
| 11/28/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Travel and Lodging | In-kind items and services | $345.53 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 11/26/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $920.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,450.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,335.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $1,038.96 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,035.00 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $137.46 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Travel and Lodging | Cash or cash equivalent | $56.89 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | Cash or cash equivalent | $35.77 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | In-kind items and services | $12.58 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
| 11/14/2024 | Optinose US, Inc. | Xhance (Drug) | Food and Beverage | Cash or cash equivalent | $10.60 | General |
| Category: Otolaryngology (Ear, Nose, Throat) | ||||||
About Dr. Sally Bailey, MD
Dr. Sally Bailey, MD is a Allergy healthcare provider based in Baltimore, Maryland. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/02/2006. The National Provider Identifier (NPI) number assigned to this provider is 1700815677.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sally Bailey, MD has received a total of $269,204 in payments from pharmaceutical and medical device companies, with $82,553 received in 2024. These payments were reported across 746 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($161,799).
Ad
Practice Information
- Specialty Allergy
- Other Specialties Pediatric Allergy/Immunology, Allergy & Immunology
- Location Baltimore, MD
- Active Since 07/02/2006
- Last Updated 07/28/2025
- Taxonomy Code 207KA0200X
- Entity Type Individual
- NPI Number 1700815677
Products in Payments
- DUPIXENT (Biological) $92,390
- Xhance (Drug) $88,017
- Odactra (Drug) $31,894
- NUCALA (Biological) $16,179
- XOLAIR (Drug) $4,381
- Auvi-Q (Drug) $3,765
- RINVOQ (Biological) $2,891
- Xembify (Biological) $2,863
- EUCRISA (Drug) $520.16
- ORLADEYO (Drug) $517.31
- ImmunoCAP (Device) $500.00
- DUPIXENT DUPILUMAB INJECTION (Biological) $447.83
- AYVAKIT (Drug) $371.34
- AUVI-Q (Drug) $366.89
- CIBINQO (Drug) $350.89
- QVAR (Drug) $322.33
- CINQAIR (Drug) $257.57
- BREO (Drug) $253.48
- Dymista (Drug) $242.48
- VTAMA (Drug) $218.60
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Allergy Doctors in Baltimore
Dr. Jody Tversky, M.d, M.D
Allergy — Payments: $195,994
Allergy $195,994
David Golden, M.d, M.D
Allergy — Payments: $132,282
Allergy $132,282
Newton Adkinson, M.d, M.D
Allergy — Payments: $130,754
Allergy $130,754
Peter Creticos, M.d, M.D
Allergy — Payments: $61,242
Allergy $61,242
Robert Wood, M.d, M.D
Allergy — Payments: $19,805
Allergy $19,805
Dr. Gitika Dhillon
Allergy — Payments: $8,057
Allergy $8,057